Have amyloid researchers had the formula for graceful aging and no neurodegeneration under their microscopes all along? At least in nematodes, that seems to be the case, according to a study posted in the March 30 Nature online. The aggregate dye thioflavin T—also known as Basic Yellow 1—and a host of related compounds boost the lifespan of Caenorhabditis elegans by nearly two weeks. That’s a serious extension for worms that normally only live for three weeks. Related compounds such as curcumin, the active ingredient in the bright yellow spice turmeric, also slowed aging. First author Silvestre Alavez and senior author Gordon Lithgow, of the Buck Institute for Research on Aging in Novato, California, report that the dye may work on a broad range of aggregates by promoting the worms’ own cellular machinery for protein homeostasis. The exact mechanism is far from clear, and no one is advocating a thioflavin treatment for people anytime soon. However, “I must admit I’m eating more curries than I used to,” Lithgow said.

Alavez started with an interest in amyloid-binding dyes and related molecules, he said, because “these chemical compounds have a particular chemical structure that allows them to physically interact with proteins prone to aggregate.” Perhaps, he hypothesized, they might bind to small oligomeric aggregates and interfere with amyloid formation. Others have proposed that polyphenols (Porat et al., 2006) and the dye Congo red (Frid et al., 2006) can block amyloid fibrillization.

The first experiment was a flop; Alavez treated worms with the dyes and the worms died at the normal time. A year later, he decided to try again with higher drug concentrations. This time, the worms kept wriggling for four, even five weeks; five of the 10 compounds he tried created Methuselah nematodes. Thioflavin T extended lifespan by up to 78 percent; curcumin and another molecule, rifamicin, added up to 45 percent to a worm’s days. And they were active days, too; age-matched worms on thioflavin were much more motile than their untreated counterparts (see videos).

Control: Untreated worms that survive to 20 days barely move.

Treated: 20-day-old worms treated with thioflavin T still slither across the plate.

Image credits: Silvestre Alavez, Buck Institute for Research on Aging, Novato, California

The researchers wondered if thioflavin T might also battle diseases of aging, such as Alzheimer’s disease. They used two worm models to test this idea: one expressing an amyloid-β peptide and the other producing a polyglutamine peptide. Normally, these worms become paralyzed. Under thioflavin or curcumin treatment, half or fewer of the amyloid-β worms froze in their tracks. The effect on the polyglutamine strain was not as dramatic, but was statistically significant.

Finally, the researchers wondered whether thioflavin T directly represses aggregation, or if it interacts indirectly with worm genes and proteins to extend lifespan. RNAi interference of several genes blocked thioflavin T’s ability to reduce paralysis, indicating those genes were part of a thioflavin T-induced pathway. Chaperones and proteins involved in ubiquitin-mediated proteolysis and lysosomal protein degradation were essential to the thioflavin T’s effects on paralysis. Conversely, RNAi for some genes increased the drug’s effects, indicating that those proteins normally stand in the way of the drug’s activity. According to these experiments, Daf-16, a FOXO-like transcription factor involved in aging (see ARF related news story on Wolff et al., 2006 and Berman et al., 2006), represses this life-prolonging pathway. Skn-1, a transcription factor that promotes stress response and longevity was necessary for thioflavin T’s efficacy. Skn-1 is the homologue of mammalian Nrf-2; it promotes stress resistance and longevity.

In another set of experiments designed to measure lifespan, the researchers focused on Daf-16, Hsf-1, and Skn-1—transcription factors needed for normal lifespan. Hsf-1 is a chaperone that promotes disaggregation (see ARF related news story). A mutation in any of these proteins abolished thioflavin T’s life-extending effects.

Lithgow proposes that aging itself results from a loss of protein homeostasis, and neurodegeneration is an extreme version of this process (see also ARF related news story on David et al., 2010). He and Alavez found that an amyloid-specific antibody, A11, binds to unknown protein structures in elderly worms even if they do not express amyloid-β, suggesting there are many kinds of aggregates in old animals.

Lithgow imagines that in aging neurons, the production of misfolded protein “garbage” simply outpaces the trash removal system. Large aggregates like amyloid-β are the most noticeable fallout from poor homeostasis, but many other proteins may also be affected. “Who knows how many other oligomers we have forming in our bodies that never fibrillize into visible lesions…yet still cause problems?” agreed Rudy Tanzi of Massachusetts General Hospital, who was not involved in the study.

The mechanism by which thioflavin improved these worms’ lives, however, remains unknown. Tanzi, who is co-founder of a company developing small molecules that transport metal ions, speculated that the dye dissolved amyloids, freeing up metal ions that the cell needs (see ARF related news story on Adlard et al., 2008). Lithgow suspects that the dyes, as a first step, bind to amyloid and other misfolded proteins. “By some means, this may trigger a genomic response,” he said. However, Alavez was unable to show conclusively that thioflavin bound to amyloids. In immuno-localization studies of amyloid-β, he observed that the dye was located near the aggregates, but also all over the cell. He fears that fixing and staining the tissue may have rinsed away some of the thioflavin, clouding the results.

“I am not aware that thioflavin T slows Aβ aggregation…most people use this environment-sensitive fluorophore because it doesn’t alter the kinetics of aggregation directly,” wrote Jeff Kelly of The Scripps Research Institute in La Jolla, California, in an e-mail to ARF. “It is not clear to me that this compound quantitatively alters aggregate load…the ability of thioflavin T to interact with and promote the proper folding of misfolding-prone proteins seems unlikely,” added Kelly, who was not part of the study.

However it does it, thioflavin appears to activate the cell’s stress response machinery, which supports protein homeostasis and keeps the worms alive. Several investigators not involved in the study questioned what that mechanism might be. “It is not clear exactly how these compounds turn on these pathways,” said Chris Link of the University of Colorado in Boulder. He noted that the effect could be direct or indirect. The mechanism might, but does not necessarily have to, involve amyloid binding, said Greg Cole of the University of California in Los Angeles. Alternatively, he posited, thioflavin T and the like might simply be toxins, to which the cell responds by ramping up protective mechanisms. Indeed, high doses of thioflavin T were lethal, and worms on lower doses had reduced fertility.

Basic Yellow 1 joins curcumin (see ARF related news story on Yang et al., 2004), Congo red, and methylene blue (see ARF related news story and Necula et al., 2007)—not to mention red wine (see ARF related news story on Ladiwala et al., 2010), coffee (Dostal et al., 2010), and blueberries (see ARF related news story on Joseph et al., 2003)—in a veritable rainbow of potentially protective compounds. Another colorful stain for amyloid, and an analogue of thioflavin T, is Pittsburgh compound B, or PIB. Radioactive PIB lights up plaques on a PET scan (see ARF related news story on Bacskai et al., 2007). “That is encouraging; at least someone has actually put that into a person,” Lithgow said. Neither thioflavin T nor curcumin cross the blood-brain barrier, but other related life-prolonging compounds do, Alavez said.

“It does not want to make me treat people with thioflavin T derivatives just yet,” cautioned Bill Klunk of the University of Pittsburgh, who was not involved with the study. “It is a first step of many more needed steps.”—Amber Dance

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. The remarkable life-extending activity of the high curcumin concentrations requires additional experimental data for evaluation. Aqueous solutions of curcumin are not stable over three days (see decreased toxicity in zebrafish embryo); there are even reports on curcumin half-life to be less than 30 minutes and on phototoxicity of the aqueous solutions. How did the authors determine thioflavin and curcumin concentration in the agar plates at day 10, 20, or 30? This can be achieved by calibrated UV/VIS absorption.

    Did the agents alter the E. coli cultures in any way? Curcumin is known to inhibit E. coli growth at far lower concentrations! Maybe some of the nematodes entered the Dauer stage due to restricted growth of E. coli, which recovers after curcumin depletion. Could this result in the observation of "extended lifespan," which is actually due to an extended Dauer stage? The later Dauer stage results in a related paralysis that may result in a false-positive "dead" assignment. Thus, the reports of their "death may be greatly exaggerated."

    References:

    . Curcumin affects development of zebrafish embryo. Biol Pharm Bull. 2007 Jul;30(7):1336-9. PubMed.

    . Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal. 1997 Aug;15(12):1867-76. PubMed.

    . Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ--a structural insight to unveil antibacterial activity of curcumin. Eur J Med Chem. 2010 Sep;45(9):4209-14. PubMed.

References

News Citations

  1. A Matter of Life and DAF: Pathways to Longevity Revealed in <I>C. Elegans</I>
  2. Keystone: Longevity, Insulin-like Growth Factor Signaling, and Aβ Toxicity
  3. Protein Aggregation: It’s Not Just for Disease Anymore
  4. Improving Cognition in Mice: Copper Ionophore Shows Some Mettle
  5. Curry Ingredient Spices Things Up by Blocking Aβ Aggregation
  6. Vienna (and Burkina Faso): What's New With Methylene Blue?
  7. One Small Molecule Detoxifies Different Forms of Aβ
  8. Blueberries for All?
  9. It Is Official: Autopsy Verifies Human PIB-Amyloid Connection

Paper Citations

  1. . Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des. 2006 Jan;67(1):27-37. PubMed.
  2. . Congo red and protein aggregation in neurodegenerative diseases. Brain Res Rev. 2007 Jan;53(1):135-60. PubMed.
  3. . SMK-1, an essential regulator of DAF-16-mediated longevity. Cell. 2006 Mar 10;124(5):1039-53. PubMed.
  4. . Germ-cell loss extends C. elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone signaling. Cell. 2006 Mar 10;124(5):1055-68. PubMed.
  5. . Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol. 2010;8(8):e1000450. PubMed.
  6. . Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron. 2008 Jul 10;59(1):43-55. PubMed.
  7. . Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005 Feb 18;280(7):5892-901. PubMed.
  8. . Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry. 2007 Jul 31;46(30):8850-60. PubMed.
  9. . Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J Biol Chem. 2010 Jul 30;285(31):24228-37. PubMed.
  10. . Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β-amyloid peptide toxicity. Genetics. 2010 Nov;186(3):857-66. PubMed.
  11. . Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci. 2003 Jun;6(3):153-62. PubMed.
  12. . Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol. 2007 Mar;64(3):431-4. PubMed.

Further Reading

Papers

  1. . Disassembly of preformed amyloid beta fibrils by small organofluorine molecules. Bioorg Med Chem Lett. 2011 Apr 1;21(7):2044-7. PubMed.
  2. . Curcuminoid binds to amyloid-β1-42 oligomer and fibril. J Alzheimers Dis. 2011;24 Suppl 2:33-42. PubMed.
  3. . Protective effect of curcumin (Curcuma longa) against D-galactose-induced senescence in mice. J Asian Nat Prod Res. 2011 Jan;13(1):42-55. PubMed.
  4. . Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism. Pharmacol Res. 2011 May;63(5):439-44. PubMed.
  5. . Nitrosative stress-induced Parkinsonian Lewy-like aggregates prevented through polyphenolic phytochemical analog intervention. Biochem Biophys Res Commun. 2011 Jan 7;404(1):324-9. PubMed.
  6. . Tetrahydrocurcumin confers protection against amyloid β-induced toxicity. Neuroreport. 2011 Jan 5;22(1):23-7. PubMed.

Primary Papers

  1. . Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature. 2011 Apr 14;472(7342):226-9. PubMed.